Conference Program

Each session of the conference integrates presentations in clinical, translational and fundamental research.
07:45 – Registration
08:30 – Welcome:
  • Rudi Balling, Director, Luxembourg Centre for Systems Biomedicine, University of Luxembourg
  • Rejko Krüger, PEARL Chair and Head, Clinical and Experimental Neuroscience,  Luxembourg Centre for Systems Biomedicine, University of Luxembourg
08:45 – Keynote: Jules A. Hoffmann, Nobel Prize in Physiology or Medicine 2011, Professor at University of Strasbourg for Advanced Study, Chair of Integrative Biology
              “Innate Immunity: From Insects to Humans”

Introduction: what do translational medicine and patients’ associations expect from research?
09:35 –  Ulf Nehrbass, CEO, Luxembourg Institute of Health
              “What does translational medicine expect from research?”
09:55 – Mary Baker, Former President of the European Brain Council
              “Societal and Health Challenges of Europe”
10:15 – Coffee break with poster session and industry exhibition

Session 1: Genetics in Parkinson’s disease – are we ready fo the next step?
10:45 – Clinical –  Karl Kieburtz, Professor of Neurology, University of Rochester
             “New approaches for future trials on neuroprotective therapies in PD”
11:15 – Translational – Lena Burbulla, Research Assistant Professor, Department of Neurology ,Feinberg School of Medicine, Northwestern University
11:45 – FundamentalThomas Gasser, Director, Department of Neurodegenerative Diseases and Professor of Neurology, Hertie-Institute for Clinical Brain Research, University of Tübingen
             “Progress in genetics research on Parkinson’s disease”
12:15 – Sean Sapcariu, Programme Manager, Luxembourg National Research Fund
             “FNR Funding Opportunities”

12:25 – Lunch, poster session & industry exhibition

Session 2: New strategies to prevent neurodegeneration
13:30 – Clinical – Christine von Arnim, Professor of Neurology, Ulm University
14:00  – Translational – Anja Schneider, Director, Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Clinic Bonn / Group leader at German Center for Neurodegenerative Diseases
             “Fluid biomarkers for early detection of neurodegenerative diseases”
14:30 – FundamentalRussell Swerdlow, Director of neurodegerative Disease Programm and Alzheimer’s Disease Center,Institute for Reproductive Health and Regenerative Medicine, University of Kansas School of Medicine
             “Mitochondrial Dysfunction, mtDNA and Neurodegeneration”
15:00 – Young researcher
15:15 – Coffee break with poster session and industry exhibition

Session 3: Smart devices and sensor-based technologies
15:45 – ClinicalJochen Klucken, Vice Head, Department of Molecular Neurology at the University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg
             “The role of sensor based technologies in future health care concepts”
16:15 – TranslationalJens Clausen, Head of Department Ethics and Lifesciences and their Didactics, University of Education, Freiburg
             “Brain-machine interfaces and ethical dimensions of neuroprosthetics”
16:45 – FundamentalLara Mangravite, President, Sage Bionetworks
             “Smartphones-based monitoring of PD symptoms”
17:15 – Young researcher
17:30 – Wrap up

18:30 – Networking dinner, Hall des Poches, Campus Belval
07:45 – Registration
08:20 – Keynote – Caroline M. Tanner, Professor, Department of Neurology, University of California School of Medicine, San Francisco
Session 4: Is Parkinson’s disease ready for precision medicine?
09:00 – Clinical –  Nobutaka Hattori, Professor and Chairman, Department of Neurology, Juntendo University
             “The translational impact of monogenic Parkinson’s disease”
09:30 – TranslationalRonan T. Fleming, Assistant Professor, Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Faculty of Science, Leiden University
10:00 – Coffee break with poster session and industry exhibition
10:30 – Fundamental – Olga Corti, Research Director, French National Institute of Health and Medical Research (Inserm)
             “The PINK1/Parkin pathway and its dysfunction in Parkinson’s disease”
11:00 – Young Researcher

Session 5 Cohorts as test beds
11:15 – ClinicalWolfgang Oertel, Hertie-Senior-Research-Professor, Department of Neurology, Philipps University Marburg
11:45 – Translational – Alastair Noyce, Clinical Senior Lecturer in Preventive Neurology, Queen Mary University of London
           “Emerging concepts for web-based assessment of risk cohorts for Parkinson’s disease
12:15 – FundamentalPaul Wilmes, Principal Investigator, Luxembourg Centre for Systems Biomedicine, University of Luxembourg
12:45 – Young researcher

13:00 – Lunch, poster session & industry exhibition

Session 6: Multidisciplinary approach to PD care
14:00 – Clinical – Pille Taba, Professor of Neurology, University of Tartu
           “Emerging concepts for integrated management of Parkinson’s disease”
14:20 – ClinicalElke Kalbe, Head of Department Medical Psychology, University Clinic Cologne
           “Cognitive training as an intervention to prevent dementia?”
14:40 – ClinicalMariella Graziano, President of the Association of Physiotherapists in Parkinson ’s disease Europe
15:00 – ClinicalGritt Mallien, speechtherapist and practice owner, Doktor Logo
15:20  – Panel discussion
15:50 – Wrap up and closing
15:55 Coffee break